09
Oct
EADV: TNF Inhibitor Active in Palmoplantar Psoriasis (CME/CE) (source: Med Page Today)
Posted by: admin // Category: ObjectBERLIN (MedPage Today) — Patients with palmoplantar psoriasis had at least 50% improvement after 14 weeks when treated with a tumor necrosis factor (TNF) inhibitor, according to results of a small clinical trial reported here. (source: Med Page Today) - RSS and News widget on Feedzilla.com
View original post here:
EADV: TNF Inhibitor Active in Palmoplantar Psoriasis (CME/CE) (source: Med Page Today)
Tags: patients, psoriasis-had, small-clinical, tnf, today, trial-reported, tumor-necrosis